Fecal Transplant Treatments Could Transmit Monkeypox, FDA Warns

WEDNESDAY, Aug. 24, 2022 (HealthDay News) -- Fecal microbiota for transplantation (FMT) treatments could infect patients with monkeypox, the U.S. Food and Drug Administration has warned.
Since May, an outbreak of monkeypox has been spreading in multiple countries, including the United States. Nearly 16,000 people in the United States have already been infected with the virus, which is transmitted through close physical contact with symptomatic individuals.
Monkeypox virus DNA has been found in rectal swabs and stool samples from infected people, the FDA said in its alert, which was issued this week. That includes one study where monkeypox virus was found in three people who reported no symptoms of the disease, the agency said.
"FDA is advising that clinical use of FMT has the potential to transmit monkeypox virus," the alert said. As a result, the FDA has recommended donor screening for clinical trials involving fecal transplants if the studies involve stool donated on or after March 15, 2022. Patients should also be informed of the monkeypox risk, the agency added.
Related Posts
Unas relaciones sanas podrían resultar en unos cuerpos más sanos, muestra un estudio
MARTES, 28 de marzo de 2023 (HealthDay News) -- Unas relaciones cercanas, y si...
Fatigue Can Plague People With MS. Exercise May Help
WEDNESDAY, Aug. 9, 2023 (HealthDay News) -- Patients with a type of multiple...
Overweight/Obese BMI Linked to Worse Survival in Young People With Leukemia
THURSDAY, July 13, 2023 (HealthDay News) -- For adolescents and young adults...
AHA News: 11 cosas a saber para salvar una vida con RCP
MIÉRCOLES, 1 de febrero de 2023 (American Heart Association News) -- Cuando un...
